Services
Van Leeuwenhoeck Research offers the following products and services:
- Company Research & Valuation
- Road shows & Press Tours
- Matchmaking
- Contract research
- Asset Management/Trading Ideas
Company Research & Valuation
Van Leeuwenhoeck Research provides continuing research coverage on both listed and private Life Sciences companies.
The one-year coverage commences with an "institutional-quality” initial report, followed by three quarterly updates that are issued by the analyst following the release of subsequent quarterly earnings. Additionally, research notes issued periodically, comment on changes in our ratings or analyses or on major company announcements (such as a new breakthrough, new key personnel, new product developments). This package can be extended with specific intermediate updates which address certain news facts. As with all quality research programs, the analyst spends time with management and thoroughly reviews each company's industry and competitive position. The analyst maintains close contact with the management of the company during the course of the coverage cycle.
Road shows & Press Tours
With the Company Research reports you create a basis for enhanced visibility in the marketplace. You can significantly increase your visibility when you also choose to let us organise road shows. We distinguish two distinct target groups to address in the roadshows:
- the professional investors
- media
We engage professional and specialised communication agencies with footholds in the Life Sciences sector and in the investment community specialised in biotech. De Mello’s extended contact database is a rich resource we tap. Road shows are organised per country and can take up to three days in three different cities if necessary. Specific details are being negotiated with the client.
Matchmaking
Road shows (also) aimed at raising investment money with the investment community serve another purpose then merely visibility and awareness creation. In that case we offer our investment brokerage services (matchmaking) in the deal. Van Leeuwenhoeck Research uses her own networks and those of selected international business partners to address the right investors, considerably increasing your chances of raising money for your next financing round.
Contract research
Research Reports for Life Sciences and other innovative companies are primarily aimed at investors and the life sciences sector in general. But we also address our research at financial companies such as investment bankers. Due to limited deal flow and increased costs involved in maintaining industry-specific analysts many banks do no longer invest in dedicated biotech analysts. In order to present their customers with up-to-date biotech market information procuring biotech research is a valid and cost-effective solution to this problem.
Asset Management
Van Leeuwenhoeck Research has created three models:
- Model portfolio I is focused at USA-listed biotech companies
- Model portfolio II is focused at European biotech companies
- Model portfolio III is focused at life sciences from emerging markets and Asia
Each model portfolio has a multi-year track record. Every single company in each portfolio has a profile that is continuously kept up-to-date. Asset management departments of investment banks specialised in biotech may find these model portfolios a useful tool, that can also be offered to their customers. This allows them to buy in the specific expertise not at hand in their own company. Via our biweekly newsletter Trading Tribune we keep you informed what is hot and what not in the global life sciences sector. Trading Tribune provides you with up to date information and traders tips, which is grouped among one or more of the mentioned portfolios.